Literature DB >> 1004640

Catabolism of vasoactive polypeptides by perfused rat liver.

D R Borges, E A Limãos, J L Prado, A C Camargo.   

Abstract

Exsanguinated rat liver preparations perfused in situ with oxygenated saline solutions inactivated recirculating bradykinin (BK) at rates of 2.3 to 9.1 and isoleucyl5 angiotensin II (AII) at rates of 2.8 to 15.0 nmoles X min-1 X g-1 of liver, depending on the initial concentration of the peptides in the perfusion fluid (3.1 to 18.9 X 10(-6) M for BK and 8.5 to 17.0 X 10(-6) M for AII). On the other hand, at similar concentrations, recirculation of isoleucyl5 Angiotensin I (AI) for 8 min did not lead to decrease of its biological activity when assayed on the isolated rat uterus. Following a single passage through liver, picomole amounts of both BK and AII were inactivated by about 90% as revealed by assays on a superfused rat uterus. The potency ratio AI:AII, assayed on a superfused rat uterus was 1:22 and changed to 1:5 following a single passage of both peptides through liver. This finding and the separation of 4.9% of AII on carboxymethylcellulose columns following recirculation of AI through rat liver indicate a conversion of AI into AII. The dipeptides Phe-Arg, Ser-Pro and Gly-Phe were identified among the hydrolysis products of perfused BK. A peptidyldipeptide hydrolase (EC 3.4.15) may be responsible for both the BK inactivation and AI conversion. The inactivation of AII cannot be attributed to the same enzyme.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1004640     DOI: 10.1007/bf00509769

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  16 in total

Review 1.  Pharmacokinetic function of the pulmonary circulation.

Authors:  Y S Bakhle; J R Vane
Journal:  Physiol Rev       Date:  1974-10       Impact factor: 37.312

2.  The renin--angiotensin system: inhibition of converting enzyme in isolated tissues.

Authors:  J W Aiken; J R Vane
Journal:  Nature       Date:  1970-10-03       Impact factor: 49.962

Review 3.  The release and fate of vaso-active hormones in the circulation.

Authors:  J R Vane
Journal:  Br J Pharmacol       Date:  1969-02       Impact factor: 8.739

4.  Removal of angiotensin by isolated perfused organs of the rat.

Authors:  W P Leary; J G Ledingham
Journal:  Nature       Date:  1969-06-07       Impact factor: 49.962

5.  Preparation, assay, and partial characterization of a neutral endopeptidase from rabbit brain.

Authors:  A C Camargo; R Shapanka; L J Greene
Journal:  Biochemistry       Date:  1973-04-24       Impact factor: 3.162

6.  Pulmonary extractionof bradykinin and eledoisin.

Authors:  P Biron
Journal:  Rev Can Biol       Date:  1968-03

7.  Inactivation of bradykinin in the pulmonary circulation.

Authors:  J W Ryan; J Roblero; J M Stewart
Journal:  Biochem J       Date:  1968-12       Impact factor: 3.857

8.  The disappearance of bradykinin and eledoisin in the circulation and vascular beds of the cat.

Authors:  S H Ferreira; J R Vane
Journal:  Br J Pharmacol Chemother       Date:  1967-06

9.  [Histamine-liberating substances and the process of liberation of endogenous histamine].

Authors:  B N HALPERN
Journal:  Actual Pharmacol (Paris)       Date:  1960

10.  Recovery and conversion of kinins in exsanguinated rat preparations.

Authors:  J L Prado; E A Limãos; J Roblero; J O Freitas; E S Prado; A C Paiva
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1975       Impact factor: 3.000

View more
  4 in total

1.  Studies on the hydrolysis of bradykinin by angiotensin-converting enzyme (kininase II).

Authors:  F E Dorer; J M Stewart; J W Ryan
Journal:  Experientia       Date:  1978-11-15

2.  Bradykinin inactivation by perfused rat liver. Role of a thiol activated endopeptidase.

Authors:  D R Borges; J A Guimarães; E A Limãos; J L Prado; A C Camargo
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-11       Impact factor: 3.000

3.  Angiotensin II or epinephrine hemodynamic and metabolic responses in the liver of L-NAME induced hypertension and spontaneous hypertensive rats.

Authors:  Debora Conte Kimura; Marcia Regina Nagaoka; Durval Rosa Borges; Maria Kouyoumdjian
Journal:  World J Hepatol       Date:  2017-06-18

4.  Participation of hepatic α/β-adrenoceptors and AT1 receptors in glucose release and portal hypertensive response induced by adrenaline or angiotensin II.

Authors:  L J T de Araújo; M R Nagaoka; D R Borges; M Kouyoumdjian
Journal:  Braz J Med Biol Res       Date:  2018-11-14       Impact factor: 2.590

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.